Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy

Related Experiment Video

Updated: Mar 8, 2026

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

8.0K

Anish Babu, Ranganayaki Muralidharan, Narsireddy Amreddy

    IEEE Transactions on Nanobioscience
    |January 17, 2017
    PubMed

    Insights

    Small interfering RNA (siRNA) offers cancer gene silencing but requires effective delivery. Nanoparticles, especially liposomes, are explored as safe vehicles for enhanced siRNA therapy in vivo.

    Area of Science:

    • Biotechnology
    • Molecular Biology
    • Nanomedicine

    Background:

    • Gene silencing via RNA interference (RNAi) is a promising strategy for targeting cancer-causing genes.
    • Small interfering RNA (siRNA) is a key RNAi tool with therapeutic potential in oncology.
    • Current siRNA therapies face challenges like instability, poor cellular uptake, and degradation, necessitating efficient delivery systems.

    Purpose of the Study:

    • To review nanoparticle systems for siRNA delivery in cancer therapy.
    • To highlight liposome-based gene delivery systems.
    • To discuss methods for improving nanoparticle-mediated siRNA delivery for enhanced specificity and efficiency.

    Main Methods:

    • Review of current literature on nanoparticle-based siRNA delivery systems.
    • Focus on liposome-based formulations.
    • Analysis of strategies to enhance target specificity and efficiency.

    Main Results:

    • Various nanoparticle systems are utilized for siRNA delivery in cancer therapy.
    • Liposome-based systems are emphasized for their potential.
    • Methods exist to improve targeting and efficiency of nanoparticle-siRNA delivery.

    Conclusions:

    • Nanoparticles, particularly liposomes, are crucial for overcoming siRNA delivery challenges in cancer therapy.
    • Strategies to enhance specificity and efficiency are vital for successful in vivo applications.
    • Further development is needed for safe and effective nanoparticle-based siRNA delivery systems.

    More Related Videos

    Nanoparticle-mediated siRNA Gene-silencing in Adult Zebrafish Heart09:12

    Nanoparticle-mediated siRNA Gene-silencing in Adult Zebrafish Heart

    Published on: July 29, 2018

    8.6K
    Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery08:53

    Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

    Published on: April 16, 2019

    8.3K

    Related Concept Videos

    siRNA - Small Interfering RNAs02:30

    siRNA - Small Interfering RNAs

    Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
    In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
    18.9K
    Experimental RNAi02:15

    Experimental RNAi

    RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
    8.1K
    Small interfering RNAs (siRNA)02:30

    Small interfering RNAs (siRNA)

    5.1K
    RNA Interference01:23

    RNA Interference

    RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
    This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
    28.4K
    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
    24.5K
    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
    4.2K